A global survey of potential acceptance of a COVID-19 vaccine

Nat Med. 2021 Feb;27(2):225-228. doi: 10.1038/s41591-020-1124-9. Epub 2020 Oct 20.

Abstract

Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June 2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates and factors influencing acceptance of a COVID-19 vaccine. Of these, 71.5% of participants reported that they would be very or somewhat likely to take a COVID-19 vaccine, and 48.1% reported that they would accept their employer's recommendation to do so. Differences in acceptance rates ranged from almost 90% (in China) to less than 55% (in Russia). Respondents reporting higher levels of trust in information from government sources were more likely to accept a vaccine and take their employer's advice to do so.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • COVID-19 / epidemiology*
  • COVID-19 / immunology*
  • COVID-19 / virology
  • COVID-19 Vaccines / adverse effects
  • COVID-19 Vaccines / immunology*
  • Female
  • Humans
  • Internationality*
  • Male
  • Middle Aged
  • Patient Acceptance of Health Care*
  • Regression Analysis
  • SARS-CoV-2 / immunology
  • Surveys and Questionnaires*
  • Young Adult

Substances

  • COVID-19 Vaccines